JWCA
ABBV icon

J.W. Coons Advisors’s AbbVie ABBV Stock Holding History

J.W. Coons Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.8M Buy
9,691
+24
+0.2% +$4.46K 0.41% 64
2025
Q1 		$2.03M Sell
9,667
-247
-2% -$48K 0.53% 52
2024
Q4 		$1.76M Sell
9,914
-315
-3% -$57.9K 0.45% 57
2024
Q3 		$2.02M Sell
10,229
-75
-0.7% -$14K 0.5% 52
2024
Q2 		$1.77M Sell
10,304
-5
-0% -$828 0.43% 56
2024
Q1 		$1.88M Sell
10,309
-37
-0.4% -$6.38K 0.42% 52
2023
Q4 		$1.6M Sell
10,346
-154
-1% -$22.5K 0.43% 56
2023
Q3 		$1.57M Sell
10,500
-780
-7% -$115K 0.45% 53
2023
Q2 		$1.52M Sell
11,280
-720
-6% -$106K 0.42% 56
2023
Q1 		$1.91M Sell
12,000
-2,890
-19% -$442K 0.55% 48
2022
Q4 		$2.41M Sell
14,890
-1,600
-10% -$245K 0.72% 41
2022
Q3 		$2.21M Buy
16,490
+569
+4% +$81.7K 0.84% 36
2022
Q2 		$2.43M Sell
15,921
-154
-1% -$23.5K 0.86% 32
2022
Q1 		$2.6M Buy
16,075
+151
+0.9% +$21.9K 0.77% 38
2021
Q4 		$2.16M Sell
15,924
-2,297
-13% -$271K 0.65% 43
2021
Q3 		$1.97M Buy
18,221
+146
+0.8% +$16.7K 0.67% 43
2021
Q2 		$2.03M Sell
18,075
-412
-2% -$46.4K 0.72% 42
2021
Q1 		$2M Buy
18,487
+957
+5% +$102K 0.72% 40
2020
Q4 		$1.88M Buy
17,530
+5,214
+42% +$501K 0.72% 41
2020
Q3 		$1.08M Buy
12,316
+1,641
+15% +$154K 0.45% 60
2020
Q2 		$1.05M Buy
10,675
+1,106
+12% +$97.4K 0.47% 64
2020
Q1 		$730K Buy
+9,569
New +$815K 0.38% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

J.W. Coons Advisors's ABBV Position: Q2 2025 in Review

J.W. Coons Advisors increased its AbbVie (ABBV) stake by 0.25% in Q2 2025, buying an estimated $4.46K and bringing the position to 9,691 shares worth $1.8M. The position accounts for 0.41% of the portfolio, ranked #64.

J.W. Coons Advisors first reported a position in ABBV in Q1 2020 and has held it in 22 quarters since. The position peaked at $2.6M in Q1 2022. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • J.W. Coons Advisors held 9,691 shares of AbbVie worth $1.8M as of Q2 2025.
  • J.W. Coons Advisors bought 24 AbbVie shares in Q2 2025, an estimated $4.46K.
  • AbbVie made up 0.41% of J.W. Coons Advisors's portfolio in Q2 2025, its #64 holding.
  • J.W. Coons Advisors first reported a position in AbbVie in Q1 2020 and has held it in 22 quarters since.
  • J.W. Coons Advisors's AbbVie position peaked at $2.6M in Q1 2022.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.